Suppr超能文献

端粒酶假尿嘧啶合成酶的C末端延伸是先天性角化不良的突变热点,可调节与端粒酶RNA的相互作用及亚细胞定位。

The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.

作者信息

Qin Jian, Garus Alexandre, Autexier Chantal

机构信息

Department of Anatomy and Cell Biology, McGill University, 3640 University Street, Montreal, Quebec, QC H3A 0C7, Canada.

Lady Davis Institute, Jewish General Hospital, 3755 Chem, de la Côte-Sainte-Catherine, Montréal, QC H3T 1E2, Canada.

出版信息

Hum Mol Genet. 2024 Feb 1;33(4):318-332. doi: 10.1093/hmg/ddad180.

Abstract

Dyskerin is a component of the human telomerase complex and is involved in stabilizing the human telomerase RNA (hTR). Many mutations in the DKC1 gene encoding dyskerin are found in X-linked dyskeratosis congenita (X-DC), a premature aging disorder and other related diseases. The C-terminal extension (CTE) of dyskerin contributes to its interaction with the molecular chaperone SHQ1 during the early stage of telomerase biogenesis. Disease mutations in this region were proposed to disrupt dyskerin-SHQ1 interaction and destabilize dyskerin, reducing hTR levels indirectly. However, biochemical evidence supporting this hypothesis is still lacking. In addition, the effects of many CTE disease mutations on hTR have not been examined. In this study, we tested eight dyskerin CTE variants and showed that they failed to maintain hTR levels. These mutants showed slightly reduced but not abolished interaction with SHQ1, and caused defective binding to hTR. Deletion of the CTE further reduced binding to hTR, and perturbed localization of dyskerin to the Cajal bodies and the nucleolus, and the interaction with TCAB1 as well as GAR1. Our findings suggest impaired dyskerin-hTR interaction in cells as a previously overlooked mechanism through which dyskerin CTE mutations cause X-DC and related telomere syndromes.

摘要

端粒酶假尿嘧啶合成酶是人类端粒酶复合物的一个组成部分,参与稳定人类端粒酶RNA(hTR)。在X连锁先天性角化不良(X-DC)这一早衰性疾病及其他相关疾病中,发现了许多编码端粒酶假尿嘧啶合成酶的DKC1基因突变。端粒酶假尿嘧啶合成酶的C末端延伸(CTE)在端粒酶生物合成早期有助于其与分子伴侣SHQ1相互作用。该区域的疾病突变被认为会破坏端粒酶假尿嘧啶合成酶与SHQ1的相互作用,使端粒酶假尿嘧啶合成酶不稳定,从而间接降低hTR水平。然而,仍缺乏支持这一假设的生化证据。此外,许多CTE疾病突变对hTR的影响尚未得到研究。在本研究中,我们检测了8种端粒酶假尿嘧啶合成酶CTE变体,结果显示它们无法维持hTR水平。这些突变体与SHQ1的相互作用略有降低但并未消除,并导致与hTR的结合缺陷。CTE的缺失进一步降低了与hTR的结合,并扰乱了端粒酶假尿嘧啶合成酶在卡哈尔体和核仁中的定位,以及与TCAB1和GAR1的相互作用。我们的研究结果表明,细胞中端粒酶假尿嘧啶合成酶与hTR的相互作用受损是一种此前被忽视的机制,端粒酶假尿嘧啶合成酶CTE突变通过该机制导致X-DC和相关的端粒综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/9b1ea52876df/ddad180ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验